Notice ID: e1baa77a8343447b8f7a952cc3fa3156Combined Synopsis/Solicitation
Venous Thrombosis (VT)
Active, responses due . Combined Synopsis/Solicitation posted by NATIONAL AERONAUTICS AND SPACE ADMINISTRATION on September 28, 2026. Solicitation 80JSC026Q0014.
NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). Place of performance: 36208, Texas. Full description on SAM.gov.
Description
Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30.
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Overview
Agency:
National Aeronautics and Space Administration
Office:NASA JOHNSON SPACE CENTER
Posted:September 28, 2026
NAICS:541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Last Updated:Sep 28, 2026
PSC:AN22: R&D- MEDICAL: DRUG DEPENDENCY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Response Deadline:
Set-Aside:Not specified
Type:Combined Synopsis/Solicitation
Place of Performance:36208, Texas
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
John Russo
Secondary Contact
Katelyn Jaime
Documents
Select documents to download
Showing 9 of 9 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 85.21 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 972.9 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 19.93 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 98.28 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 141.36 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 972.94 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 156.85 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 972.94 KB | |||
| Combined Synopsis/Solicitation | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | Sep 28, 2026 | 100.76 KB |
Lifecycle
Solicitation:
80JSC026Q0014- Combined Synopsis
- 2×Combined SynopsisCurrentSep 25, 2026
Venous Thrombosis (VT)
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Amendment 1: This RFI was amended to update the response due date to October 14, 2026, 2:00 p.m. CT. NASA/Johnson Space Center (JSC) is hereby requesting information for Measurement of Core Temperature and Thermoregulatory Responses during and after Spaceflight in Astronauts. For further details see attachment: 80JSC027CTTR RFI 2026-09-29 All responses must be submitted electronically via email to Tracy L. Quintanilla at Tracy.L.Quintanilla@nasa.gov, and Katelyn R. Jaime at Katelyn.R.Jaime@nasa.gov, no later than October 7, 2026, 2:00 p.m CT. Please reference: RFI 80JSC027CTTR - Measurement of Core Temperature and Thermoregulatory Responses during and after Spaceflight in Astronauts, in any response. | Market Research | 541715 | No Set-Aside | 09/30/2026 | 10/14/2026 | 36208, TX | |
NASA/Johnson Space Center (JSC) is hereby requesting information for Measurement of Core Temperature and Thermoregulatory Responses during and after Spaceflight in Astronauts. For further details see attachment: 80JSC027CTTR RFI 2026-09-29 All responses must be submitted electronically via email to Tracy L. Quintanilla at Tracy.L.Quintanilla@nasa.gov, and Katelyn R. Jaime at Katelyn.R.Jaime@nasa.gov, no later than October 7, 2026, 2:00 p.m CT. Please reference: RFI 80JSC027CTTR - Measurement of Core Temperature and Thermoregulatory Responses during and after Spaceflight in Astronauts, in any response. | Market Research | 541715 | No Set-Aside | 09/29/2026 | 10/07/2026 | 36208, TX | |
Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination. The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference. The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price. FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any). Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted. Responses to this combined synopsis/solicitation must be received via email no later than 1:00PM CST on 11/20/2026. The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines. Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services. | Combined Synopsis | 541715 | No Set-Aside | 09/25/2026 | 11/20/2026 | 36208, TX | |
This is modification no. 2 to the special notice entitled "80JSC025CLDPacquisitionUPDATE2024DEC” which was posted on Dec 20, 2024. You are notified that the following changes are made: NASA will no longer hold an acquisition briefing (initially planned for January 2025) and instead provide updated presentation slides and answers to industry’s questions. The following files are attached: “CLDP Phase 2 Acquisition Industry Update – Revised 27JAN2025” “Questions and Answers from Dec 2024 Acq. Update” NASA plans to provide additional opportunities to communicate to industry and intends to hold future acquisition strategy briefings as the acquisition strategy progresses. ************* end of modification ************* This is a modification no. 1 to the special notice entitled "80JSC025CLDPacquisitionUPDATE2024DEC” which was posted on Dec 20, 2024. You are notified that the following changes are made: The due date for responses is extended. All questions/comments must be submitted electronically via email to Rogelio Curiel at rogelio.curiel-1@nasa.gov no later than 5:00pm EST on Jan 10, 2025. The next acquisition briefing is tentatively planned the week of Jan 20, 2025 (additional details are forthcoming and will be posted on SAM.gov). ************* end of modification ************* This is a Special Notice and does not constitute a commitment, implied or otherwise, that the National Aeronautics and Space Administration (NASA) will take action in this matter. Background: As NASA plans for the retirement of the International Space Station at the end of the decade, the ability of private industry to take on the task of providing routine utilization of low-Earth orbit (LEO) and maintaining a continuous U.S. presence in space is of vital importance to both NASA and U.S. goals. In a multiphase strategy, the Lyndon B. Johnson Space Center’s (JSC) Commercial Low-Earth Orbit Development Program (CLDP) is helping to spur the development of new low-Earth orbit space destinations and supporting systems from private industry. These systems may include end-to-end services such as the in-orbit destination, visiting vehicles, and supporting launch vehicles and ground systems. NASA is currently developing requirements for Commercial LEO Destination (CLD) capabilities to safely support operations of NASA astronauts and spaceflight participants in LEO on a commercially owned and operated space system. See the links here for additional information: https://www.nasa.gov/leo-economy/low-earth-orbit-economy/ and NASA's Low Earth Orbit Microgravity Strategy. Purpose: NASA’s CLDP is providing an industry update per the attached presentation slides to communicate the CLD’s Phase 2 acquisition strategy. Industry is invited to provide input in the form of written questions and/or comments to support NASA’s evolving acquisition strategy and enable NASA to refine and mature the Phase 2 acquisition strategy. All questions/comments must be submitted electronically via email to Rogelio Curiel at rogelio.curiel-1@nasa.gov no later than 5:00pm EST on Jan 7, 2025. Please reference "80JSC025CLDPacquisitionUPDATE2024DEC" in any response. Telephone questions will not be accepted. NASA expects to provide additional information in the form of questions and answers; therefore interested parties should note that any questions submitted and their corresponding answers will be posted on this website on a non-attributable basis. NASA plans to provide additional opportunities to communicate to Industry and intends to hold future acquisition strategy briefings. The next acquisition briefing is tentatively planned the week of Jan 13, 2025 (additional details are forthcoming and will be posted on SAM.gov). No solicitation exists; therefore, do not request a copy of the solicitation. If a solicitation is released, it will be synopsized on SAM.gov. Interested firms are responsible for monitoring this website for the release of any solicitation or synopsis. | Special Notice | 541715 | No Set-Aside | 01/28/2026 | 01/10/2025 | Houston, TX | |
08/31/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: Focus Area 1 section 1.6.5, Relative Importance of Factors, has been amended and posted to NSPIRES. ______________________________________________________________________________________________________ 06/22/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: A revision to the ISS NASA Research Announcement (NRA) NNJ13BG001NNRA has been posted to NSPIRES. This revision amends Section 1.2.9 (Data Management Plan), Section 1.3 (Submission Dates and Times), Section 1.4.1 (Step 1 – White Paper Submission), and Section 1.6.5 (Relative Importance of Factors). Attachment G (InSPA Question and Answers) has also been updated and posted to NSPIRES. The due date of 06/23/2023 for Advanced Materials and Manufacturing white papers has not been extended. ______________________________________________________________________________________________________ 06/20/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: A revision to the ISS NASA Research Announcement (NRA) NNJ13BG001NNRA has been posted to NSPIRES. This revision corrects the white paper page limitation in section 1.4.1 to 11 pages and revised section 1.6.5. _______________________________________________________________________________________________________ 06/01/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: Updated Attachment G, Questions & Answers. This updated document is available in NSPIRES. ________________________________________________________________________________________________________ 05/15/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: The National Aeronautics and Space Administration (NASA) has announced an opportunity for U.S. entities seeking to develop and demonstrate In Space Production Applications (InSPA) on the International Space Station (ISS) National Lab (NL). This opportunity is made available on NSPIRES through the ISS NASA Research Announcement (NRA) NNJ13BG001N, Focus Area 1 “In Space Production Applications (InSPA)." This notice is for Cycle 2023-2 InSPA Phase 1 concepts in the area of Advanced Materials and Manufacturing. NASA requests the submission of white papers by June 23, 2023, followed by proposals (by invitation only) that focus on applications that use space to serve markets on Earth. Proposals should demonstrate the potential of space to produce superior materials and products over what can be achieved on Earth for important terrestrial applications. _____________________________________________________________________________________________ 04/06/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: additional Questions & Answers have been posted to NSPIRES. _________________________________________________________________________________________ 03/17/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: Questions & Answers have been posted to NSPIRES. _____________________________________________________________________________________________________ 03/10/2023 - This is a modification to the synopsis entitled In Space Production Applications (InSPA) NASA Research Announcement (NRA), 80JSC023INSPA, which was posted on February 15, 2023. You are notified that the following changes are made: The National Aeronautics and Space Administration (NASA) is announcing an opportunity for U.S. entities seeking to develop and demonstrate In Space Production Applications (InSPA) on the International Space Station (ISS) National Lab (NL). This opportunity is made available through the ISS NASA Research Announcement (NRA) NNJ13BG001N, Special Focus Area 1 “In Space Production Applications (InSPA)." This notice is for InSPA Phase 1 concepts in the area of Tissue Engineering and Biomanufacturing. NASA requests the submission of white papers followed by proposals (by invitation only) that focus on applications that use space to serve markets on Earth. Proposals should demonstrate the potential of space to produce superior biomaterials and products over what can be achieved on Earth for important terrestrial applications. The final amendment to Focus Area 1 has been published to NSPIRES. The white paper due date has been extended to April 7, 2023. The National Aeronautics and Space Administration (NASA) is announcing an opportunity for U.S. entities seeking to develop and demonstrate In Space Production Applications (InSPA) on the International Space Station (ISS) National Lab (NL). This opportunity is made available through the ISS NASA Research Announcement (NRA) NNJ13BG001N, Special Focus Area 1 “In Space Production Applications (InSPA)”, link listed in the attachments/links section. The ISS remains the premier microgravity research and development laboratory for those seeking to develop and demonstrate technologies for in-space production of new and higher performing products for use on Earth. NASA intends to make awards through this Focus Area to enable commercially viable and sustainable business opportunities in low-Earth orbit (LEO) that advance solutions for national interest or public benefit by leveraging the capabilities and resources of the ISS. NASA intends through these awards to provide the support needed by United States non-governmental entities during early-stage development to validate game-changing materials and production processes that give U.S. industry a competitive edge amidst increasing global competition. For more information on NASA’s InSPA Portfolio, visit www.nasa.gov/inspa. This notice is for InSPA Phase 1 concepts in the area of Tissue Engineering and Biomanufacturing. NASA requests the submission of white papers followed by proposals (by invitation only) that focus on applications that use space to serve markets on Earth. Proposals should demonstrate the potential of space to produce superior biomaterials and products over what can be achieved on Earth for important terrestrial applications. A draft of the amendment to Focus Area 1 is posted for industry review and comment. Comments are requested to be submitted to the NRA Manager, Colleen Corbett, via email at colleen.corbett@nasa.gov no later than 4 pm Central time on March 1, 2023. The anticipated release date of the final Focus Area 1 amendment is on or about March 8, 2023, with an anticipated white paper due date of on or about March 31, 2023. The NAICS Code and Size Standard are 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and 1,000 employees, respectively. If a solicitation is released, then it and any additional documents will be available on SAM.gov and NASA Solicitation and Proposal Integrated Review and Evaluation System (NSPIRES). Potential applicants are urged to access NSPIRES well in advance of the white paper and proposal due date(s) of interest to familiarize themselves with its structure and enter the requested identifier information. It is the offeror's responsibility to monitor this website for the release of the solicitation and amendments (if any). Potential offerors will be responsible for downloading their own copy of the solicitation and amendments (if any). | Special Notice | 541715 | No Set-Aside | 11/25/2024 | 06/23/2023 | - |
Additional Details
Solicitation Number
80JSC026Q0014
Archive Date
Dec 5, 2026
Office Address
HOUSTON, TX, 77058